Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
N4 Pharma ( (GB:N4P) ) just unveiled an announcement.
N4 Pharma PLC has announced a change in its major holdings, with Mathenz Marc Kay crossing a voting rights threshold to hold 9.12% of the company’s voting rights, up from a previous 8.36%. This change reflects a significant shift in shareholder composition, potentially impacting the company’s governance and strategic decisions.
More about N4 Pharma
N4 Pharma PLC is a pharmaceutical company focused on developing novel delivery systems for vaccines and therapeutics. The company operates within the biotech industry and aims to enhance the effectiveness of existing drugs through its proprietary technologies.
YTD Price Performance: 4.76%
Average Trading Volume: 2,042,705
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £5.97M
For a thorough assessment of N4P stock, go to TipRanks’ Stock Analysis page.